These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 34052871)

  • 1. Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity.
    Valent P; Degenfeld-Schonburg L; Sadovnik I; Horny HP; Arock M; Simon HU; Reiter A; Bochner BS
    Semin Immunopathol; 2021 Jun; 43(3):423-438. PubMed ID: 34052871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes.
    Valent P; Klion AD; Roufosse F; Simon D; Metzgeroth G; Leiferman KM; Schwaab J; Butterfield JH; Sperr WR; Sotlar K; Vandenberghe P; Hoermann G; Haferlach T; Moriggl R; George TI; Akin C; Bochner BS; Gotlib J; Reiter A; Horny HP; Arock M; Simon HU; Gleich GJ
    Allergy; 2023 Jan; 78(1):47-59. PubMed ID: 36207764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.
    Gotlib J
    Am J Hematol; 2014 Mar; 89(3):325-37. PubMed ID: 24577808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.
    Shomali W; Gotlib J
    Am J Hematol; 2024 May; 99(5):946-968. PubMed ID: 38551368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causes of hypereosinophilia in 100 consecutive patients.
    Moller D; Tan J; Gauiran DTV; Medvedev N; Hudoba M; Carruthers MN; Dehghan N; van den Berghe J; Bruyère H; Chen LYC
    Eur J Haematol; 2020 Sep; 105(3):292-301. PubMed ID: 32364630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypereosinophilic Syndrome.
    Curtis C; Ogbogu P
    Clin Rev Allergy Immunol; 2016 Apr; 50(2):240-51. PubMed ID: 26475367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypereosinophilic syndromes.
    Roufosse FE; Goldman M; Cogan E
    Orphanet J Rare Dis; 2007 Sep; 2():37. PubMed ID: 17848188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypereosinophilic syndrome and proliferative diseases.
    Ionescu MA; Wang L; Janin A
    Acta Dermatovenerol Croat; 2009; 17(4):323-30. PubMed ID: 20021987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Spectrum of Hypereosinophilia and Associated Clonal Disorders - A Real-World Data Based on Combined Retrospective and Prospective Analysis from a Tropical Setting.
    Sreedharanunni S; Varma N; Sachdeva MUS; Naseem S; Malhotra P; Bansal D; Trehan A; Varma S
    Mediterr J Hematol Infect Dis; 2018; 10(1):e2018052. PubMed ID: 30210745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in diagnosis and treatment of eosinophilia.
    Sheikh J; Weller PF
    Curr Opin Hematol; 2009 Jan; 16(1):3-8. PubMed ID: 19057198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic therapies for hypereosinophilic disorders: From tyrosine kinase inhibitors to monoclonal antibodies. Towards an increasingly customized management?
    Iurlo A; Cattaneo D
    Blood Rev; 2023 Mar; 58():101014. PubMed ID: 36153195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imatinib for the treatment of hypereosinophilic syndromes.
    Helbig G
    Expert Rev Clin Immunol; 2018 Feb; 14(2):163-170. PubMed ID: 29303368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypereosinophilic syndromes: pathogenic and therapeutic up-to-date].
    Kahn JE; Grandpeix-Guyodo C; Ackermann F; Charles P; Legrand F; Blétry O
    Rev Med Interne; 2010 Apr; 31(4):268-76. PubMed ID: 20303627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and therapeutic management in patients with hypereosinophilic syndromes.
    Helbig G; Kyrcz-Krzemień S
    Pol Arch Med Wewn; 2011; 121(1-2):44-52. PubMed ID: 21346698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The Hypereosinophilic Syndromes in Childhood].
    Leu T; Simon HU; Hebestreit H; Kunzmann S
    Klin Padiatr; 2015 Nov; 227(6-7):308-13. PubMed ID: 26267413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Diagnostic Work-Up of Hypereosinophilia.
    Wang SA
    Pathobiology; 2019; 86(1):39-52. PubMed ID: 29961056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypereosinophilic syndromes].
    Groh M; Lefèvre G; Ackermann F; Étienne N; Kahn JE
    Rev Prat; 2019 Sep; 69(7):767-773. PubMed ID: 32233322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic Agents for the Treatment of Hypereosinophilic Syndromes.
    Kuang FL; Klion AD
    J Allergy Clin Immunol Pract; 2017; 5(6):1502-1509. PubMed ID: 29122152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypereosinophilic syndrome--recent developments in diagnosis and treatment].
    Hellmich B; Holl-Ulrich K; Gross WL
    Dtsch Med Wochenschr; 2007 Sep; 132(37):1892-6. PubMed ID: 17823882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypereosinophilic syndromes - An enigmatic group of disorders with an intriguing clinical spectrum and challenging treatment.
    Helbig G; Klion AD
    Blood Rev; 2021 Sep; 49():100809. PubMed ID: 33714638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.